'Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate

International Urology and Nephrology

Volumn 32, Issue 1, 2000, Pages 77-79

  Cervenakov, Il'ja ^a   Kopecny, Marien ^a   Jancar, Marien ^a   Chovan, Daniel ^a   Mal'a, Milan ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

'Hot flush'; Androgens; Carcinoma of the prostate; Centre of termoregulation; Hypophysis catecholamines; Hypothalamus

Indexed keywords

ALPRAZOLAM; ANTIANDROGEN; BROMAZEPAM; CATECHOLAMINE; CYPROTERONE ACETATE; PREDNISONE; TESTOSTERONE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DELIVERY SYSTEM; GYNECOMASTIA; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPOPROTEINEMIA; LIBIDO; MALE; ORCHIECTOMY; PROSTATE CARCINOMA; SEXUAL DYSFUNCTION; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; HOT FLASHES; HUMANS; MALE; MIDDLE AGED; ORCHIECTOMY; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0033765373     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007164319067     Document Type: Article

References (17)

1. Prostate cancer, an introduction
2. Hormonal treatment of advanced prostate cancer
3. Carcinoma of the prostate
4. Studies on prostatic cancer II. The effects of castration on advanced carcinoma of prostate gland
5. Physiologic basis for hormonal therapy in carcinoma of the prostate
6. Advances and trends in hormonal therapy for advanced prostate cancer
7. Appearance, origin mechanism and therapy of 'hot flushes' after bilateral orchiectomy for prostate cancer
8. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of prostate
9. Intracrinology its impact on prostate cancer
10. Hot flushes after orchiectomy in treatment of prostate cancer-A serious side effect
11. A prospective randomized study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma
12. Androcur 50 in the treatment of prostatic carcinoma. Belgian multicentric study with the participation of 30 urologists
13. Transdermal clonidine for ameliorating postorchiectomy hot flushes
14. Therapy of vasomotor syndrome in the treatment of advanced prostatic cancer apropos of 37 cases
15. Maximum androgen blockade using LH-RH agonist busurelin in combination with short term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis of EROTC GU Group Trial 30843. European Organisation for Research and Treatment of Cancer (EROTC). Genito-Urinary Tract Cancer Cooperative Group
16. Luteinizing hormone releasing hormone agonist in prostate cancer. Elimination of flare reaction by pre-treatment with cyproterone acetate and low-dose diethylstilbestrol
17. Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer